Ming-Kuei Jang - Publications

Merck, Boston, Boston, MA, United States 
neurodegenerative diseases; synaptic functions; novel biomarker discovery

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Kostakis E, Smith C, Jang MK, Martin SC, Richards KG, Russek SJ, Gibbs TT, Farb DH. The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism. Molecular Pharmacology. 84: 261-74. PMID 23716622 DOI: 10.1124/mol.113.085696  0.96
2011 Kostakis E, Jang MK, Russek SJ, Gibbs TT, Farb DH. A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons. Journal of Neurochemistry. 119: 486-96. PMID 21883211 DOI: 10.1111/j.1471-4159.2011.07442.x  0.96
2004 Jang MK, Mierke DF, Russek SJ, Farb DH. A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 101: 8198-203. PMID 15150412 DOI: 10.1073/pnas.0401838101  0.96
Show low-probability matches.